{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:50:13Z","timestamp":1762869013711,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Nature and Science Foundation","award":["81703903"],"award-info":[{"award-number":["81703903"]}]},{"name":"Beijing University of Traditional Chinese Medicine Dongzhimen Hospital 2020 Science and Technology Innovation Project","award":["DZMKJCX-2020-024"],"award-info":[{"award-number":["DZMKJCX-2020-024"]}]},{"DOI":"10.13039\/501100019540","name":"Science Fund for Distinguished Young Scholars of Zhejiang Province","doi-asserted-by":"publisher","award":["Q23H270006"],"award-info":[{"award-number":["Q23H270006"]}],"id":[{"id":"10.13039\/501100019540","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scientific research Fund project of Zhejiang Chinese Medical University","award":["2022JKZKTS31"],"award-info":[{"award-number":["2022JKZKTS31"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Rationale<\/jats:title>\n                <jats:p>Immune thrombocytopenia (ITP) is thought to be a result of immune dysfunction, which is treated by glucocorticoids such as prednisone. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) have immunomodulatory properties, but their role in intestinal immune control is unclear. The major goal of this study was to look at the effects of prednisone on platelet, VIP, and PACAP levels in ITP mice, as well as the regulatory system that controls intestinal immunity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Eighteen BALB\/c mice were randomly divided into three groups: blank control group, model control group, and prednisone group, with six mice in each group. The ITP animal model control group and the prednisone group were injected with anti-platelet serum (APS) to replicate the ITP animal model. The prednisone group began prednisone intervention on the 8th day. Platelet count was dynamically measured before APS injection, on the 4th day of injection, on the 1st day of administration, on the 4th day of administration, and at the end of the experiment. After the experiment, the expression of p53 protein in mouse mesenteric lymph node lymphocytes was detected by immunohistochemistry. The changes in lymphocyte apoptosis rate in mouse mesenteric lymph nodes were detected by in situ terminal transferase labeling (TUNEL). The contents of VIP and PACAP in the mouse brain, colon, and serum were detected by enzyme-linked immunosorbent assay (ELISA). The contents of IFN-\u03b3, IL-4, IL-10, IL-17A in the mouse spleen were detected by ELISA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>\u2460Changes of peripheral platelet count: there was no significant difference in platelet count among the three groups before modeling; on the 4th day, the platelet count decreased in the model control group and prednisone group; on the 8th day, the number of platelets in model control group and prednisone group was at the lowest level; on the 12th day, the platelet count in prednisone group recovered significantly; on the 15th day, the platelet count in prednisone group continued to rise. \u2461Changes of VIP, PACAP: compared with the blank control group, VIP and PACAP in the model control group decreased significantly in the brain, colon, and serum. Compared with the model control group, the levels of VIP and PACAP in the brain, colon, and serum in the prednisone group were increased except for serum PACAP. \u2462Changes of mesenteric lymphocytes: the expression of p53 protein in the mesenteric lymph nodes of model control group mice was significantly higher than that of blank control group mice. After prednisone intervention, the expression of p53 protein decreased significantly.\u2463Changes of cytokines in spleen: compared with blank control group, IFN- \u03b3, IL-17A increased and IL-4 and IL-10 decreased in model control group. After prednisone intervention, IFN- \u03b3, IL-17A was down-regulated and IL-4 and IL-10 were upregulated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Prednisone-upregulated VIP and PACAP levels decreased P53 protein expression and apoptosis rate in mesenteric lymph node lymphocytes and affected cytokine expression in ITP model mice. Therefore, we speculate that the regulation of intestinal immune function may be a potential mechanism of prednisone in treating ITP.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40001-023-00987-x","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T03:05:29Z","timestamp":1675825529000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Research on the mechanism of prednisone in the treatment of ITP via VIP\/PACAP-mediated intestinal immune dysfunction"],"prefix":"10.1186","volume":"28","author":[{"given":"Xiang","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yayue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,8]]},"reference":[{"issue":"23","key":"987_CR1","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","volume":"3","author":"C Neunert","year":"2019","unstructured":"Neunert C, Terrell DR, Arnold DM, et al. American society of hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3(23):3829\u201366.","journal-title":"Blood Adv"},{"issue":"2","key":"987_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/jcm6020016","volume":"6","author":"A Zufferey","year":"2017","unstructured":"Zufferey A, Kapur R, Semple JW. Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP). J Clin Med. 2017;6(2):16.","journal-title":"J Clin Med"},{"issue":"6","key":"987_CR3","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.autrev.2017.04.012","volume":"16","author":"S Audia","year":"2017","unstructured":"Audia S, Mahevas M, Samson M, et al. Pathogenesis of immune thrombocytopenia. Autoimmun Rev. 2017;16(6):620\u201332.","journal-title":"Autoimmun Rev"},{"key":"987_CR4","first-page":"1010","volume":"19","author":"L Zhang","year":"2016","unstructured":"Zhang L, Chen K, Li T, et al. Prednisone provokes serum and vasoactive substances in a mice model of immune thrombocytopenia. Iran J Basic Med Sci. 2016;19:1010\u20135.","journal-title":"Iran J Basic Med Sci"},{"issue":"2","key":"987_CR5","first-page":"91","volume":"2","author":"T Li","year":"2015","unstructured":"Li T, He H, Hou L, et al. Regulation of non-classical immune parameters in immune thrombocytopenic purpura mice by a spleen-invigorating, qi-replenishing and blood-containing formula. J Tradit Chin Med Sci. 2015;2(2):91\u20138.","journal-title":"J Tradit Chin Med Sci"},{"key":"987_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-011-1184-8","author":"M Delgado","year":"2013","unstructured":"Delgado M, Ganea D. Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions. Amino Acids. 2013. https:\/\/doi.org\/10.1007\/s00726-011-1184-8.","journal-title":"Amino Acids"},{"issue":"1","key":"987_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1476-5381.2012.01871.x","volume":"166","author":"AJ Harmar","year":"2012","unstructured":"Harmar AJ, Fahrenkrug J, Gozes I, et al. Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR Review 1. British J Pharmacol. 2012;166(1):4.","journal-title":"British J Pharmacol"},{"key":"987_CR8","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fcimb.2019.00154","volume":"9","author":"CA Figueiredo","year":"2019","unstructured":"Figueiredo CA, Dusedau HP, Steffen J, et al. immunomodulatory effects of the neuropeptide pituitary adenylate cyclase-activating polypeptide in acute toxoplasmosis. Front Cell Infect Microbiol. 2019;9:154.","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"987_CR9","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/apha.12427","volume":"213","author":"D Ganea","year":"2015","unstructured":"Ganea D, Hooper KM, Kong W. The neuropeptide vasoactive intestinal peptide: direct effects on immune cells and involvement in inflammatory and autoimmune diseases. Acta Physiol (Oxf). 2015;213(2):442\u201352.","journal-title":"Acta Physiol (Oxf)"},{"issue":"10","key":"987_CR10","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nri3738","volume":"14","author":"AM Mowat","year":"2014","unstructured":"Mowat AM, Agace WW. Regional specialization within the intestinal immune system. Nat Rev Immunol. 2014;14(10):667\u201385.","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"987_CR11","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1080\/00365521.2017.1349173","volume":"52","author":"B Ahluwalia","year":"2017","unstructured":"Ahluwalia B, Magnusson MK, Ohman L. Mucosal immune system of the gastrointestinal tract: maintaining balance between the good and the bad. Scand J Gastroenterol. 2017;52(11):1185\u201393.","journal-title":"Scand J Gastroenterol"},{"issue":"11","key":"987_CR12","doi-asserted-by":"publisher","first-page":"e80362","DOI":"10.1371\/journal.pone.0080362","volume":"8","author":"M Tauschmann","year":"2013","unstructured":"Tauschmann M, Prietl B, Treiber G, et al. Distribution of CD4(pos) -, CD8(pos)\u2014and regulatory T cells in the upper and lower gastrointestinal tract in healthy young subjects. PLoS ONE. 2013;8(11):e80362.","journal-title":"PLoS ONE"},{"issue":"1","key":"987_CR13","doi-asserted-by":"publisher","first-page":"6304","DOI":"10.1038\/s41598-019-41684-2","volume":"9","author":"C Vadnais","year":"2019","unstructured":"Vadnais C, Chen R, Fraszczak J, et al. A novel regulatory circuit between p53 and GFI1 controls induction of apoptosis in T cells. Sci Rep. 2019;9(1):6304.","journal-title":"Sci Rep"},{"issue":"9","key":"987_CR14","first-page":"694","volume":"69","author":"L Ma","year":"2014","unstructured":"Ma L, Liang Y, Fang M, Guan Y, Si Y, Jiang F, Wang F. The cytokines (IFN-gamma, IL-2, IL-4, IL-10, IL-17) and Treg cytokine (TGF-beta1) levels in adults with immune thrombocytopenia. Pharmazie. 2014;69(9):694.","journal-title":"Pharmazie"},{"issue":"21","key":"987_CR15","doi-asserted-by":"publisher","first-page":"8011","DOI":"10.3390\/ijms21218011","volume":"21","author":"X Zhu","year":"2020","unstructured":"Zhu X, Zhu J. CD4 T helper cell subsets and related human immunological disorders. Int J Mol Sci. 2020;21(21):8011.","journal-title":"Int J Mol Sci"},{"issue":"05","key":"987_CR16","first-page":"47","volume":"32","author":"H He","year":"2015","unstructured":"He H, Xu Y, Zheng L, et al. Effect of jianpi yiqi shexue prescription on SIgA and \u03b2- EP in serum from mice models of ITP. Inf Tradit Chin Med. 2015;32(05):47\u20139.","journal-title":"Inf Tradit Chin Med"},{"issue":"1","key":"987_CR17","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s12882-019-1548-y","volume":"20","author":"D Fu","year":"2019","unstructured":"Fu D, Senouthai S, Wang J, et al. Vasoactive intestinal peptide ameliorates renal injury in a pristane-induced lupus mouse model by modulating Th17\/Treg balance. BMC Nephrol. 2019;20(1):350.","journal-title":"BMC Nephrol"},{"issue":"4","key":"987_CR18","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/eji.201141958","volume":"42","author":"W Ding","year":"2012","unstructured":"Ding W, Manni M, Stohl LL, et al. Pituitary adenylate cyclase-activating peptide and vasoactive intestinal polypeptide bias Langerhans cell Ag presentation toward Th17 cells. Eur J Immunol. 2012;42(4):901\u201311.","journal-title":"Eur J Immunol"},{"key":"987_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/978-1-4939-0897-4_9","volume":"817","author":"P Holzer","year":"2014","unstructured":"Holzer P, Farzi A. Neuropeptides and the microbiota\u2013gut\u2013brain axis. Adv Exp Med Biol. 2014;817:195\u2013219.","journal-title":"Adv Exp Med Biol"},{"key":"987_CR20","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.12688\/f1000research.18039.1","volume":"8","author":"M Iwasaki","year":"2019","unstructured":"Iwasaki M, Akiba Y, Kaunitz JD. Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system. F1000Res. 2019;8:1629.","journal-title":"F1000Res"},{"issue":"16","key":"987_CR21","doi-asserted-by":"publisher","first-page":"8682","DOI":"10.3390\/ijms22168682","volume":"22","author":"A Karpiesiuk","year":"2021","unstructured":"Karpiesiuk A, Palus K. Pituitary adenylate cyclase-activating polypeptide (PACAP) in physiological and pathological processes within the gastrointestinal tract: a review. Int J Mol Sci. 2021;22(16):8682.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"987_CR22","first-page":"156","volume":"35","author":"H Rincon-Arevalo","year":"2016","unstructured":"Rincon-Arevalo H, Sanchez-Parra CC, Castano D, et al. Regulatory B cells and mechanisms. Int Rev Immunol. 2016;35(2):156\u201376.","journal-title":"Int Rev Immunol"},{"issue":"6","key":"987_CR23","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.imbio.2019.08.006","volume":"224","author":"HT Zeng","year":"2019","unstructured":"Zeng HT, Zhao M, Yang SB, et al. Vasoactive intestinal peptide alleviates food allergy via restoring regulatory B cell functions. Immunobiology. 2019;224(6):804\u201310.","journal-title":"Immunobiology"},{"issue":"10","key":"987_CR24","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.7150\/thno.34414","volume":"9","author":"X Sun","year":"2019","unstructured":"Sun X, Guo C, Zhao F, et al. Vasoactive intestinal peptide stabilizes intestinal immune homeostasis through maintaining interleukin-10 expression in regulatory B cells. Theranostics. 2019;9(10):2800\u201311.","journal-title":"Theranostics"},{"key":"987_CR25","doi-asserted-by":"publisher","first-page":"104096","DOI":"10.1016\/j.cellimm.2020.104096","volume":"351","author":"M Kostic","year":"2020","unstructured":"Kostic M, Zivkovic N, Cvetanovic A, et al. CD4(+) T cell phenotypes in the pathogenesis of immune thrombocytopenia[J]. Cell Immunol. 2020;351:104096.","journal-title":"Cell Immunol"},{"issue":"15","key":"987_CR26","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1177\/15353702211009787","volume":"246","author":"Q Li","year":"2021","unstructured":"Li Q, Liu Y, Wang X, et al. Regulation of Th1\/Th2 and Th17\/Treg by pDC\/mDC imbalance in primary immune thrombocytopenia. Exp Biol Med (Maywood). 2021;246(15):1688\u201397.","journal-title":"Exp Biol Med (Maywood)"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-00987-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-023-00987-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-00987-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T03:06:43Z","timestamp":1675825603000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-023-00987-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,8]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["987"],"URL":"https:\/\/doi.org\/10.1186\/s40001-023-00987-x","relation":{},"ISSN":["2047-783X"],"issn-type":[{"type":"electronic","value":"2047-783X"}],"subject":[],"published":{"date-parts":[[2023,2,8]]},"assertion":[{"value":"16 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the animal ethics committee of Xi'an Medical College, Shaanxi Province. No.XYLS2019069.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors have reviewed the manuscript and agreed to publish it.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"67"}}